KMB

KMB

USD

Kimberly-Clark Corporation Common Stock

$131.610-1.350 (-1.015%)

Real-time Price

Consumer Defensive
Household & Personal Products
United States

Price Chart

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$132.960

High

$133.230

Low

$129.840

Volume

0.47M

Company Fundamentals

Market Cap

43.9B

Industry

Household & Personal Products

Country

United States

Trading Stats

Avg Volume

2.32M

Exchange

NYQ

Currency

USD

52-Week Range

Low $124.1Current $131.610High $150.45

AI Analysis Report

Last updated: Apr 21, 2025
AI-GeneratedData Source: Yahoo Finance, Bloomberg, SEC

[KMB: Kimberly-Clark Corporation]: Checking the Stock's Pulse - What's the Story?

Stock Symbol: KMB Generate Date: 2025-04-21 05:42:14

Alright, let's take a peek at Kimberly-Clark (KMB), the folks behind Kleenex, Huggies, and all those household names. We've got a bunch of recent news and some price history to chew on. What's it all telling us? Let's break it down without the Wall Street mumbo jumbo.

Recent News Buzz: A Mixed Bag of Analyst Opinions

So, what's the chatter around Kimberly-Clark lately? It's a bit of a mixed bag, honestly. We've got analysts from big firms like UBS, RBC, JP Morgan, and Wells Fargo all chiming in. The interesting thing? They don't all agree.

  • Price Targets Going Up, But Ratings All Over: Most of these analysts actually raised their price targets for KMB. Think of a price target as where they think the stock should be trading. UBS nudged theirs up to $146, Wells Fargo to $140, and even JP Morgan, who's not super keen on the stock overall, lifted their target to $131. RBC Capital is the most bullish, sticking with a $165 target.
  • The Catch? Ratings are Lukewarm: Despite the higher price hopes, the ratings themselves are pretty middle-of-the-road. UBS and Wells Fargo are "Neutral" or "Equal-Weight" – basically saying "it's okay, could go either way." JP Morgan is still "Underweight," meaning they think it's not a great pick compared to others. Only RBC is really positive with an "Outperform" rating.
  • Product News is Quietly Positive: Away from the analyst noise, there's some news about product initiatives. Poise is launching something to help women in rural areas, and there are new, improved cleaning cloths from their professional division. Huggies even has a "Poop Poncho" – sounds quirky, but it's all about keeping their brands in people's minds. These are generally good signs of a company innovating and trying to stay relevant.
  • Earnings Around the Corner: Big date to watch: April 22nd. That's when Kimberly-Clark announces their first quarter results. This is always a key moment because it gives a real snapshot of how the company is actually performing.

In plain English: Analysts are a bit unsure. They see some potential for the stock price to rise a bit, but they aren't exactly shouting from the rooftops to buy. The company itself seems to be doing its thing, launching products and getting ready to report earnings. No major red flags, but no huge excitement either.

Price Check: A Bit of a Rollercoaster Lately

Let's glance at the stock price itself. Over the last month or so, it's been a bit of a bumpy ride.

  • Early Rise, Then a Dip: If you look back to late January and February, KMB's stock price was generally climbing. It went from around $126 up to a high of $150 in early March. That's a pretty good jump. But then, things cooled off.
  • March and April: Down and Sideways: From that March peak, the price started to slide back down. Through March and into April, it's been mostly moving sideways, bouncing around in the $138 to $143 range. It's not crashing, but it's definitely not zooming up anymore either.
  • Current Price in Context: Right now, the stock is around $140. That's below its recent high, but still higher than where it was a few months ago. It's kind of in the middle of its recent range.
  • AI's Crystal Ball Says... Slightly Up? The AI prediction model is suggesting a tiny bump today (basically flat), and then a small increase over the next couple of days – maybe around 2-3% total. Not a massive surge, but not down either.

What this means: The stock had a nice run-up earlier, but it's lost some steam. It's currently in a bit of a holding pattern. The AI thinks it might inch up a little, but nothing dramatic is expected right away.

Putting It Together: Outlook and Some Possible Moves

So, what do we make of all this? Time to connect the dots and think about what it might mean for investors.

  • Near-Term Lean: Cautiously Neutral to Slightly Positive. Given the mixed analyst views but slightly raised price targets, the recent price stabilization, and the AI's mild upward prediction, the very short-term outlook isn't screaming "buy" or "sell." It's more like a "maybe lean slightly positive, but be careful" situation.
  • Why "Slightly Positive"? The fact that analysts are raising price targets, even if they aren't super enthusiastic ratings-wise, is a small plus. The AI prediction, while modest, is also pointing up. And the company seems to be operating normally, with product news and earnings coming soon.
  • Why "Cautiously Neutral"? Those lukewarm analyst ratings are a reminder that there's no strong consensus pushing this stock higher right now. The price has been flat recently, showing a lack of strong buying interest. And there are always broader market risks to consider.
  • Potential Entry Point? Maybe Around Now, or on a Dip. If you were thinking of getting into KMB, the current price range of around $140-$143 could be an area to consider. It's not far off the recent lows in this sideways range. If the price dips a bit lower, say towards $139, that might be an even more interesting spot to look for an entry, if you believe in a potential short-term bounce. But again, be cautious.
  • Where to Think About Selling or Setting a Stop? For taking profits, if the AI's prediction plays out and the stock does nudge up, maybe look at the $145-$146 area – that's where some of those analyst price targets are. For risk management, a stop-loss below the recent lows, perhaps around $137 or even a bit lower at $135, could make sense. This is just to protect yourself if the stock decides to head south instead.

Key Thing to Watch: Earnings on April 22nd. That's the big event. The actual results and what the company says about the future will likely be a much bigger driver of the stock price than these analyst tweaks or short-term AI predictions.

Company Context Reminder: Kimberly-Clark is in the business of everyday essentials – diapers, toilet paper, tissues. People buy these things no matter what the economy is doing. That makes it a relatively stable, "consumer defensive" stock. It's probably not going to be a rocket ship, but it's also less likely to completely crash and burn.

In short: Kimberly-Clark stock is in a bit of a "wait and see" mode right now. The news is mixed, the price is stable, and the near-term outlook is cautiously neutral to slightly positive. Keep an eye on those earnings!


Disclaimer: This analysis is for informational purposes only and should not be taken as financial advice. I'm just breaking down publicly available data in a simple way. Investing in the stock market involves risk, and you could lose money. Always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Related News

Reuters

Footwear brand Skechers pulls annual forecast on trade uncertainty, shares drop

Skechers on Thursday withdrew its annual results forecast as the Trump administration's erratic trade policies fuel economic uncertainty, sending the footwear maker's shares down 7% in extended trading.

View more
Footwear brand Skechers pulls annual forecast on trade uncertainty, shares drop
Analyst Upgrades

Barclays Maintains Equal-Weight on Kimberly-Clark, Lowers Price Target to $135

Barclays analyst Lauren Lieberman maintains Kimberly-Clark with a Equal-Weight and lowers the price target from $139 to $135.

View more
Barclays Maintains Equal-Weight on Kimberly-Clark, Lowers Price Target to $135
Reuters

Procter & Gamble lowers annual forecasts as trade war hits consumer demand

Procter & Gamble on Thursday lowered its annual sales and profit forecasts after reporting a bigger-than-expected drop in third-quarter net sales as consumers slashed spending due to economic uncertainty amid an ongoing trade war.

View more
Procter & Gamble lowers annual forecasts as trade war hits consumer demand
Reuters

Kimberly-Clark's $4 billion international tissue unit set for three-way M&A fight, sources say

Southeast Asia's Royal Golden Eagle (RGE) and Asia Pulp & Paper Co (APP), as well as Brazil's Suzano SA are the final bidders for Kimberly-Clark's international tissue business valued at around $4 billion, four people said.

View more
Kimberly-Clark's $4 billion international tissue unit set for three-way M&A fight, sources say
Analyst Upgrades

RBC Capital Maintains Outperform on Kimberly-Clark, Lowers Price Target to $162

RBC Capital analyst Nik Modi maintains Kimberly-Clark with a Outperform and lowers the price target from $165 to $162.

View more
RBC Capital Maintains Outperform on Kimberly-Clark, Lowers Price Target to $162
Analyst Upgrades

Piper Sandler Maintains Overweight on Kimberly-Clark, Lowers Price Target to $156

Piper Sandler analyst Korinne Wolfmeyer maintains Kimberly-Clark with a Overweight and lowers the price target from $158 to $156.

Analyst Upgrades

Evercore ISI Group Maintains Outperform on Kimberly-Clark, Lowers Price Target to $155

Evercore ISI Group analyst Javier Escalante maintains Kimberly-Clark with a Outperform and lowers the price target from $168 to $155.

AI PredictionBeta

AI Recommendation

Bullish

Updated at: Apr 27, 2025, 09:18 AM

BearishNeutralBullish

65.8% Confidence

Risk & Trading

Risk Level3/5
Medium Risk
Suitable For
Conservative
Trading Guide

Entry Point

$131.20

Take Profit

$138.52

Stop Loss

$118.46

Key Factors

RSI at 77.1 indicates overbought conditions
PDI 6.3 is above MDI 1.8 with ADX 21.9, suggesting bullish trend
Current Price is extremely close to support level ($131.01), suggesting strong buying opportunity
Trading volume is 14.5x average (21,768), indicating extremely strong buying pressure
MACD 0.1835 is above signal line 0.1150, indicating a bullish crossover

Stay Updated

Set price alerts, get AI analysis updates and real-time market news.